Companies Directory

BioCellection is a for-profit startup, developing advanced technologies to transform unrecyclable plastics into virgin-quality chemicals for sustainable supply chains. By focusing on the 92% of plastic waste too contaminated and difficult to recycle, we are unlocking a massive resource that leads to unprecedented opportunities. OUR VISION Our modern world is enabled by plastics. To keep our world beautiful, we need to use plastic waste sustainably. We envision a future where all end-of-life plastics will be recycled indefinitely. To achieve this goal, we must develop and scale key innovations to turn plastic waste into quality products that can serve sustainable markets. OUR MISSION We're pushing the frontiers of innovation in the field of plastic recycling by developing novel, scalable, and sustainable processes that treat hard-to-recycle plastic waste. We partner with organizations to scale and deploy the inventions that we build to make big impacts around the world.

A Biocelltis é uma empresa brasileira de biotecnologia, fabricante de biomateriais avançados, especializada em engenharia de células e tecidos humanos para aplicação nos setores médico, biomédico, farmacêutico e dermocosmético. Primeira e única empresa no Brasil a produzir matriz 3D para cultura de células e reconstituição de tecidos in vitro.

Biocellvia is a french digital pathology company developing Intelligent Image Analysis solutions for pharmaceutical industry (Big Pharma, Biotechs, CRO) and academic communities involved in R&D. We have developed digital image analysis solutions, that enable to evaluate fully-automatically the level of efficacy of your lead molecules thanks to histological slides (in vitro, ex vivo, biopsies) in various pathologies such as: - Gastrointestinal (NASH, Liver fibrosis) - Respiratory (IPF, COPD, PAH) We provide image analysis as a service. Our technology evaluates your molecules with more accuracy, more reliability, more rapidity and less variability than traditional scoring methods. A full study (about 200 images) is performed in only a couple of days. http://biocellvia.com http://linkedin.com/company/biocellvia

Bioceltix is a biotech start-up which deals with the development of stem cell-based medicinal products for veterinary use. Currently, our main goal is to implement a biopharmaceuticals based on allogenic stem cells. The medicines will be primarily to serve the treatment of accompanying animals. The new product candidates will become a milestone in the field of stem cell-based biopharmaceuticals for veterinary use. As one of the first such Europe-based company, Bioceltix product intends to go through the full registration path to a marketed drugs devised by the European Medicines Agency (EMA). In the first place, there will be a clinical trials carried out, while the positive results of it will allow us for the submissions of an applications for marketing authorization for the drugs we are developing in the territory of the E.U. More about products, technology, R&D, team at Bioceltix.com.

BIOCentre is a technology and business development support organisation that will provide infrastructure and services for researchers, start-ups and existing companies in biosciences/biotechnology sector.

A balance of Agile practices with a nod towards forward thinking designs. BioCentric delivers scalable digital experiences that garner industry leading customer retention

BIOCERA is a global leader in the antioxidant hydrogen alkaline mineral water, air, and the antimicrobial bioceramics industry since 1994. BIOCERA has continued to develop eco-friendly products such as bioceramic agents: antibacterial, photocatalyst, and far infrared ray agent; water activated BIOCERA Balls for water filtration, Biocera Antioxidant Alkaline Inline Water Filters, and healthcare application products. As the pioneer in bioceramic-related fields, enthusiasm and effort have accelerated in expanding markets, reaching out to customers in over 40 countries. BIOCERA is dedicated to innovative management for the customers’ happiness and well-being.

Somos la plataforma de ciencias de la vida dedicada a la preservación del planeta y el mejoramiento de la vida humana. La empresa fue fundada en diciembre de 2001 en Rosario, Argentina, por productores agropecuarios comprometidos con el avance de la ciencia y la preservación del medio ambiente. El grupo hoy cuenta con más de 300 accionistas, incluyendo productores agropecuarios, cooperativas, grupos agro-industriales y otros actores del sector de la ciencia y las finanzas. Bioceres es accionista mayoritario de Bioceres Crops Solutions Corp. ($BIOX), primera empresa latinoamericana de biotecnología para el agro en listar en la Bolsa de Comercio de Nueva York. Bioceres Crop Solutions Corp. opera bajo las marcas Rizobacter y Bioceres Semillas, comercializando insumos de alto valor tecnológico en más de 20 países, con subsidiarias en Brasil, Paraguay, Uruguay, Bolivia, Colombia, Estados Unidos, Sud África, Francia e India. Bioceres Crop Solutions es la desarrolladora de la tecnología HB4®, único evento biotecnológico disponible hoy a nivel mundial para tolerancia a sequía y salinidad en soja y trigo. A través de Bioceres Tech Service, Bioceres es accionista de Tecnoseeds R&D Inc, INDEAR S.A. y Agrality S.A., empresas dedicadas a servicios de I+D en agrotecnologías y producción de semillas. Además, Bioceres es accionista de AGBM S.A., INMET S.A. y Héritas S.A., empresas dedicadas a molecular farming, ingeniería metabólica, y medicina de precisión, respectivamente; entre otras compañías.

Bioceros is one of Europes premier providers of GMP-ready protein producing cell lines that operates from within the PolPharma Group. Bioceros has developed a proprietary animal-component free, suspension CHO platform (named CHOBC®) that is used for stable Cell Line Development. All the Cell Line Development work that we perform is Quality Controlled. We have generated cell lines producing proteins ranging from blood proteins and monoclonal antibodies to fusion proteins and enzymes. For monoclonal antibodies, our services start based on customers wishes, either with cDNA sequences to be expressed or by generation of antibodies in rodents, followed by cloning of the sequences from selected hybridomas. Further services include immunoassays, with a particular emphasis on cell based assays, as well as down-stream process development and full analytical analysis (i.e. glycan structures, charge variants and many other relevant quality attributes). Additionally, our CHOBC® platform has enabled us to generate high-producing biosimilar expressing cell lines that have been extensively analyzed to optimize the process conditions and thus yield highly similar antibodies when compared to the originators. These cell lines are available for out-licensing or co-development in various stages of development. The people at Bioceros strongly believe that true and close collaboration speeds up selection and development of clients most viable drug candidates. Therefore, the programs are designed in a flexible way, and scientists and staff involved in the programs are easily approachable.

BioCeuticals is Australia’s leading provider of nutritional and therapeutic supplements. Renowned for manufacturing and delivering high quality integrative medicines to healthcare practitioners, BioCeuticals aims to consistently raise the standards of natural-based therapies. With quality, innovation and integrity as guiding principles, BioCeuticals is at the forefront of ensuring complementary and alternative medicines (CAMs) become an integral part of the Australian allied healthcare industry. BioCeuticals has a strong commitment to research, functional formulas and reliable practitioner support. Our supplements are recognised by qualified healthcare practitioners as well as patients; a fact that reflects our reputation as a progressive force in integrative health. The BioCeuticals practitioner-only brand is proudly owned by Australia’s largest healthcare company, Blackmores Limited. On 2 July 2012, Blackmores Limited announced its acquisition of the BioCeuticals brand, which was originally founded by the Hall family in 1993. The BioCeuticals range, brand and strategy are complementary to those of Blackmores. There is strong philosophical alignment between both companies. Blackmores is committed to preserving the practitioner-only range of nutritional and therpeutic medicine, operating the company as a stand-alone business.